Related Experiment Video

Updated: Jun 28, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias

Stephan E Lehnart1, Xander H T Wehrens, Steven Reiken

  • 1Clyde and Helen Wu Center for Molecular Cardiology, Department of Physiology and Cellular Biophysics, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.

Cell
|October 11, 2005
PubMed

Insights

Phosphodiesterase 4D (PDE4D) deficiency causes heart failure and arrhythmias by affecting RyR2 channels. Restoring RyR2 function prevents these cardiac issues, revealing a key mechanism in heart disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Pharmacology

Background:

  • Phosphodiesterases (PDEs) modulate intracellular cyclic adenosine monophosphate (cAMP) levels, influencing various cellular processes.
  • PDE inhibitors are clinically linked to heart failure and arrhythmias, but underlying mechanisms remain unclear.
  • cAMP-dependent protein kinase (PKA) plays a critical role in cardiac function and excitation-contraction (EC) coupling.

Purpose of the Study:

  • To investigate the role of phosphodiesterase 4D (PDE4D) in cardiac function and the development of heart failure and arrhythmias.
  • To elucidate the molecular mechanisms by which PDE4D deficiency impacts cardiac performance and ion channel function.

Main Methods:

  • Utilized PDE4D gene inactivation in a mouse model to study progressive cardiomyopathy and response to myocardial infarction.
  • Investigated the interaction of PDE4D3 with the cardiac ryanodine receptor 2 (RyR2)/calcium-release-channel complex.
  • Analyzed PDE4D3 levels and RyR2 phosphorylation in failing human hearts and in mouse models.

Main Results:

  • PDE4D gene inactivation led to progressive cardiomyopathy, exacerbated heart failure post-myocardial infarction, and induced cardiac arrhythmias in mice.
  • PDE4D3 was identified within the RyR2 complex, crucial for cardiac EC coupling.
  • Reduced PDE4D3 levels in failing human hearts correlated with hyperphosphorylated, "leaky" RyR2 channels, promoting cardiac dysfunction.
  • Genetic modification of RyR2 to prevent PKA phosphorylation abolished PDE4 inhibition- or deficiency-induced arrhythmias and dysfunction.

Conclusions:

  • Reduced PDE4D activity impairs RyR2 channel function, contributing to heart failure and cardiac arrhythmias.
  • The PDE4D-RyR2 interaction is a critical determinant of cardiac health and a potential therapeutic target for heart disease.

More Related Videos

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...